BUY Graphite India — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))15 May 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Graphite India Raises GrafTech Stake to 9.79%, Cumulative Investment at INR 230.38 Crores
NewsGoogle News·13 May · 4d ago
Graphite India Limited has invested INR 62.25 Crores in GrafTech International Ltd., increasing its stake from 6.82% to 9.79%. The total investment in Graftech is now INR 230.38 Crores. GrafTech is a
NSE · Acquisition·11 May · 6d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Graphite India
- BUY — Vishvesh Chauhan, ChaseAlpha7 Oct 2026 · Same day · target ₹900 · Expired
- BUY — IDBI Capital6 Oct 2026 · ~2 weeks · target ₹903 · SL hit
- BUY — Raja Venkatraman6 Oct 2026 · ~3 months · target ₹898 · SL hit
- BUY — Sumeet Bagadia, Choice Broking5 Oct 2026 · ~2 weeks · target ₹890 · SL hit
- BUY — Vikas Sethi, Sethi Finmart5 Oct 2026 · ~3 months · target ₹830 · Target hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

